ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

Biotechnology

Healthcare
$7.70 -0.75%

-$0.07 today

Market cap
$800.27M
Beta
1.06
P/E (TTM)
-6.7
EPS (TTM)
-$1.28
52W Low $7.23High $14.93

Volume 1.07M

Average 1.91M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$143.00M

FY 2025 · Annual

Net Income

-$129.47M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue001.03M1.11M1.22M
Gross Profit00(1.03M)(1.11M)(1.22M)
Gross Margin—————
Research & Development56.86M61.68M85.17M114.07M109.82M
Selling, General & Admin22.01M25.09M25.61M28.82M33.19M
Operating Expenses78.87M91.77M109.75M141.79M141.78M
Depreciation & Amortization897K966K1.03M1.11M1.22M
EBITDA(77.82M)(85.8M)(99.67M)(126.74M)(128.25M)
EBITDA Margin—————
Operating Income(78.87M)(91.77M)(110.78M)(142.9M)(143M)
Operating Margin—————
Interest Income141K2.65M10.08M00
Interest Expense02.65M000
Other Income / Expenses156K2.65M10.08M15.05M13.54M
Income Before Tax(78.72M)(89.12M)(100.7M)(127.85M)(129.47M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(78.72M)(89.12M)(100.7M)(127.85M)(129.47M)
Net Margin—————
EPS (Basic)(2.07)(2.25)(1.96)(1.83)(1.47)
EPS (Diluted)(2.07)(2.25)(1.96)(1.83)(1.47)
Weighted Avg Shares37.95M39.66M51.45M69.73M87.79M
Weighted Avg Shares (Diluted)37.95M39.66M51.45M69.73M87.79M

ORIC Earnings Waterfall · TTM

NASDAQ:ORIC · Revenue to Net Income

Key Ratios

EPS$-1.44
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-7.4
P/S Ratio0.0

Analysis

$0 of revenue converted into -$135.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.44, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 23, 2026
4Statement of changes in beneficial ownershipOct 21, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
4Statement of changes in beneficial ownershipSep 29, 2026
4Statement of changes in beneficial ownershipSep 25, 2026

How much revenue does ORIC generate?

ORIC Pharmaceuticals, Inc. (ORIC) reported $0.00 of revenue in fiscal 2025.

Is ORIC profitable?

ORIC Pharmaceuticals, Inc. (ORIC) reported -$129.47M of net income.